- Home
- AARD vs MCFT Comparison
AARD vs MCFT Comparison
Compare AARD & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | MCFT |
|---|---|---|
| Founded | 2017 | 1968 |
| Country | United States | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.2M | 311.0M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AARD | MCFT |
|---|---|---|
| Price | $13.83 | $19.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $31.11 | $22.20 |
| AVG Volume (30 Days) | ★ 276.4K | 126.5K |
| Earning Date | 02-14-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.96 |
| Revenue | N/A | ★ $287,846,000.00 |
| Revenue This Year | N/A | $9.21 |
| Revenue Next Year | N/A | $8.78 |
| P/E Ratio | ★ N/A | $24.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.88 | $14.39 |
| 52 Week High | $19.58 | $23.94 |
Technical Indicators
Market Signals| Indicator | AARD | MCFT |
|---|---|---|
| Relative Strength Index (RSI) | 55.93 | 54.66 |
| Support Level | $12.90 | $19.33 |
| Resistance Level | $15.33 | $20.78 |
| Average True Range (ATR) | 1.19 | 0.58 |
| MACD | -0.02 | 0.14 |
| Stochastic Oscillator | 33.96 | 51.44 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.